NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/04/2024
Back to search
Official data from USPTO
BME BIOMEDICAL ENTERPRISES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
03/04/2024
Trademark type
Combined
Nice classes
10
Filing date
07/12/2016
Registration date
10/03/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/04/2024
Last transaction
03/04/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/30/2014
First use in commerce
04/30/2014
Drawing code
3
Owner type
03
Owner location
Warsaw, IN
Examiner
SMITH, CYNTHIA
Law office
L70
Current location
TMEG LAW OFFICE 107
Mark description
The mark consists of the stylized letters "BME" in the shape of screws above the words "BIOMEDICAL ENTERPRISES".
Holders and representatives
Holders
DEPUY SYNTHES, INC.
BioMedical Enterprises, Inc.
Representatives
Denise I. Mroz JOHNSON & JOHNSON
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Surgical and medical productsmedicalsurgicalorthopedic implants made of artificial materials and component parts thereof and implant insertion instruments
Publications
History of USPTO decisions and trademark events.
38 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/04/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/04/2024
E815
TEAS SECTION 8 & 15 RECEIVED
09/13/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/03/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/23/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/23/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/23/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/23/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/23/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/20/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/20/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/20/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/20/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/20/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/18/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
10/03/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/01/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/31/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/31/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/28/2017
IUAF
USE AMENDMENT FILED
08/08/2017
EISU
TEAS STATEMENT OF USE RECEIVED
08/08/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/14/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/20/2016
PUBO
PUBLISHED FOR OPPOSITION
12/20/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/30/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/14/2016
ALIE
ASSIGNED TO LIE
11/07/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/21/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
10/21/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/21/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
10/21/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/21/2016
DOCK
ASSIGNED TO EXAMINER
10/21/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/19/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/18/2016
NWAP
NEW APPLICATION ENTERED
07/15/2016
Continuous trademark protection
Get notified about every new filing that threatens BME BIOMEDICAL ENTERPRISES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.